Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia

Measurable (minimal) residual disease (MRD) status in acute lymphoblastic leukemia (ALL) has largely superseded the importance of traditional risk factors for ALL, such as baseline white blood cell count, cytogenetics, and immunophenotype, and has emerged as the most powerful independent prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hein, Kyaw, Short, Nicholas, Jabbour, Elias, Yilmaz, Musa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943430/
https://www.ncbi.nlm.nih.gov/pubmed/35340663
http://dx.doi.org/10.2147/BLCTT.S270134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943430/
https://www.ncbi.nlm.nih.gov/pubmed/35340663
http://dx.doi.org/10.2147/BLCTT.S270134

Ejemplares similares